Development of an in vitro human-derived tissue model for studying virus infection and disease progression in the alveolar cells of the lungs responsible for oxygen and carbon dioxide exchange with the blood might enable the study of possible therapies for acute respiratory distress syndrome (ARDS) triggered by SARS-CoV-2.
A team of Japanese scientists has revealed a mechanism associated with an increased risk of behavioural defects among offspring of older fathers in a mouse study, with strong indications similar processes are involved in humans.
The Early Evidence Base site is among the five winners of the latest ASAPbio PreprintSprint.
EMBO publicly launches the Early Evidence Base site, an experimental platform that blends human scientific expertise with artificial intelligence (AI) to highlight scientific findings posted in preprints. Preprints are manuscripts that are publicly shared online by researchers before formal publication in a peer-reviewed journal.
Molecular markers in the blood shown to be predictive of severe COVID-19 outcomes resulting from SARS-CoV-2 coronavirus infection have been identified in a study by a Chinese research team. The study results extend understanding of the pathophysiology and clinical progress of COVID-19 with potential for identifying early during the course of infection which individuals are most at risk of developing severe conditions and requiring hospital care.
Francisco Cubillos spent most of his life in Chile, but at heart, he feels international.
Stem cell researcher Yun Xia describes her research path as “straightforward”.
Born and raised in a large city in Taiwan, Cheng-Ruei Lee had only a few opportunities to be in contact with nature as a child, but he soon got fascinated by the staggering diversity of life on Earth.
We catch up on some of the recent global activities EMBO has carried out together with Associate Member States India and Singapore and cooperation partners in Chile and Taiwan.
EMBO congratulates nine life scientists on their selection as EMBO Global Investigators. They form the second cohort of the Global Investigator Network that was launched in 2019 and will start their four-year tenure in January 2021. The new Global Investigators will receive financial support for several networking, collaboration and training activities.
